MorphoSys To Take Charge Of EUR 231 Mln After Consolidation Of Research & Discovery Functions

MARTINSRIED (dpa-AFX) - MorphoSys AG (MOR) said Thursday that it will account for a non-cash impairment charge on goodwill in the amount of about 231 million euros. The write-down results from

Related Keywords

Martinsried ,Bayern ,Germany , ,Constellation Pharmaceuticals Inc ,Constellation Pharmaceuticals ,Morphosys ,Lake ,Charge ,After ,Consolidation ,Research ,Discovery ,Functions ,